Draw air into the syringe equal to your dose volume, insert the needle through the stopper, push the air in, then invert the vial and draw out your prescribed dose
Wegovy is a prescription-only medicine containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with a BMI 30 kg/m (obesity) or 27 kg/m with weight-related comorbidities, as per NICE TA875
Tirzepatide often begins showing significant results within the first two months, depending on individual factors
Importantly, none of the gallbladder events have been linked to mortality
Wegovy and Contrave are very different, but they share several key similarities
And then there are people who report no shedding at all